Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
We observed that treatment with 50 nM calcitriol for 48 h significantly improved barrier function of 16HBE cell layers based upon two independent metrics.
Source: RESULTS. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Laboratory / cell research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
At confluence, cells were treated with U0126 for 24 h.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Calcitriol modifies tight junctions, improves barrier function, and reduces TNF‐α‐induced barrier leak in the human lung‐derived epithelial cell culture model, 16HBE 14o‐
Study design awaiting verification · Physiological Reports · 2023
Original publication title
Calcitriol modifies tight junctions, improves barrier function, and reduces TNF‐α‐induced barrier leak in the human lung‐derived epithelial cell culture model, 16HBE 14o‐
© 2023 The Authors. Physiological Reports published by Wiley Periodicals LLC on behalf of The Physiological Society and the American Physiological Society.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
Abstract
Using the 16HBE 14o‐ human airway epithelial cell culture model, calcitriol (Vitamin D) was shown to improve barrier function by two independent metrics: increased transepithelial electrical resistance (TER) and reduced transepithelial diffusion of 14C‐D‐mannitol (J m). Both effects were concentration dependent and active out to 168 h post‐treatment. Barrier improvement associated with changes in the abundance of specific tight junctional (TJ) proteins in detergent‐soluble fractions, most notably decreased claudin‐2. TNF‐α‐induced compromise of barrier function could be attenuated by calcitriol with a concentration dependence similar to that observed for improvement of control barrier function.
TNF‐α‐induced increases in claudin‐2 were partially reversed by calcitriol. The ERK 1,2 inhibitor, U0126, itself improved 16HBE barrier function indicating MAPK pathway regulation of 16HBE barrier function. Calcitriol's action was additive to the effect of U0126 in reducing TNF‐ α ‐induced barrier compromise, suggesting that calcitriol may be acting through a non‐ERK pathway in its blunting of TNF‐ α: induced barrier compromise. This was supported by calcitriol being without effect on pERK levels elevated by the action of TNF‐α.
Lack of effect of TNF‐ α on the death marker, caspase‐3, and the inability of calcitriol to decrease the elevated LC3B II level caused by TNF‐α, suggest that calcitriol's barrier improvement does not involve a cell death pathway. Calcitriol's improvement of control barrier function was not additive to barrier improvement induced by retinoic acid (Vitamin A). Calcitriol improvement and protection of airway barrier function could in part explain Vitamin D's reported clinical efficacy in COVID‐19 and other airway diseases.
Authors’ abstract
Abstract
Using the 16HBE 14o‐ human airway epithelial cell culture model, calcitriol (Vitamin D) was shown to improve barrier function by two independent metrics: increased transepithelial electrical resistance (TER) and reduced transepithelial diffusion of 14C‐D‐mannitol (J m). Both effects were concentration dependent and active out to 168 h post‐treatment. Barrier improvement associated with changes in the abundance of specific tight junctional (TJ) proteins in detergent‐soluble fractions, most notably decreased claudin‐2. TNF‐α‐induced compromise of barrier function could be attenuated by calcitriol with a concentration dependence similar to that observed for improvement of control barrier function.
TNF‐α‐induced increases in claudin‐2 were partially reversed by calcitriol. The ERK 1,2 inhibitor, U0126, itself improved 16HBE barrier function indicating MAPK pathway regulation of 16HBE barrier function. Calcitriol's action was additive to the effect of U0126 in reducing TNF‐ α ‐induced barrier compromise, suggesting that calcitriol may be acting through a non‐ERK pathway in its blunting of TNF‐ α: induced barrier compromise. This was supported by calcitriol being without effect on pERK levels elevated by the action of TNF‐α.
Lack of effect of TNF‐ α on the death marker, caspase‐3, and the inability of calcitriol to decrease the elevated LC3B II level caused by TNF‐α, suggest that calcitriol's barrier improvement does not involve a cell death pathway. Calcitriol's improvement of control barrier function was not additive to barrier improvement induced by retinoic acid (Vitamin A). Calcitriol improvement and protection of airway barrier function could in part explain Vitamin D's reported clinical efficacy in COVID‐19 and other airway diseases.
Publication and source details
Original title: Calcitriol modifies tight junctions, improves barrier function, and reduces TNF‐α‐induced barrier leak in the human lung‐derived epithelial cell culture model, 16HBE 14o‐
Elizabeth Rybakovsky; Katherine M. DiGuilio; Mary Carmen Valenzano; Sophie Geagan; Kaithlyn Pham; Ronald N. Harty; James M. Mullin
Physiological Reports · 2023
* CorrespondenceJames M. Mullin, Lankenau Institute for Medical Research, 100 Lancaster Avenue, Wynnewood, PA 19096, USA.
Email: mullinj@mlhs.org
© 2023 The Authors. Physiological Reports published by Wiley Periodicals LLC on behalf of The Physiological Society and the American Physiological Society.https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.National Institutes of Health 10.13039/100000002AI139392Sharpe‐Strumia Research Foundation
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T07:24:53.883628+00:00
DOI: 10.14814/phy2.15592 · PMC10086678